Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part LI - Optometrists › Chapter 6 - Dispensation of Medication › Section LI-611 - Mandatory Access and Review of Prescription Monitoring Program Data; Exceptions

Current through Register Vol. 50, No. 6, June 20, 2024
A. Scope of
				Rule
.
The rules for this §611 provide for prescriber mandatory
				access and review of the Louisiana Prescription Monitoring Program, R.S. 40:100
				et seq., as from time to time may be amended (PMP), and for exceptions and
				non-compliance.
B. As used in this
				§611, the following terms and phrases shall have the meanings specified.
Administer
-with respect to a medication
				  provided or dispensed by a prescriber for use by a patient, the term
administer
means directly or through an agent to give, provide
				  or supply for immediate oral ingestion, insertion or topical application by the
				  patient, or to insert, apply topically, or inject intravenously,
				  intramuscularly, subcutaneously, intrathecally, or extrathecally.
Board
-the Louisiana State Board of Optometry
				  Examiners, as constituted under
				  R.S.
				  37:1041 et seq.
Controlled Dangerous Substance (CDS)
-any
				  substance defined, enumerated or included in federal or state statute or
				  regulations  21 CFR §§ 1308.11-15  or
				  R.S.
				  40:964, or any substance which may hereafter
				  be designated as a controlled substance by amendment or supplementation of such
				  regulations and statute.
Delegate
-an individual authorized by a
				  prescriber or dispenser who is also authorized to access and retrieve
				  prescription monitoring program data for the purpose of assisting the
				  prescriber or dispenser, and for whose actions the authorizing prescriber or
				  dispenser retains accountability.
Prescribe
-to issue a request or order for a
				  drug or medical device by an individual licensed under this Part for a
				  legitimate medical purpose. The act of prescribing must be in good faith and in
				  the usual course of the licensees professional practice.
Prescriber
-an optometrist or other health
				  care provider as may hereafter be licensed by the board under this Part, whose
				  scope of practice includes authority to prescribe opioids.
Prescription
-an order from a practitioner
				  authorized by law to prescribe for a drug or device that is patient specific
				  and is communicated by any means to a pharmacist in a permitted
				  pharmacy.
Prescription Monitoring Program
or
PMP
-the electronic system for the monitoring of controlled
				  substances and other drugs of concern established by the Prescription
				  Monitoring Program Act,
				  R.S.
				  40:1001 et seq., as may from time to time be
				  amended.
C. Mandatory Access
				and Review
1. Prior to initially prescribing
				any opioid to a patient, a prescriber or his/her delegate shall access and
				review the patients record in the PMP; and
2. If opioids are prescribed to the patient
				for more than 90 days, the prescriber or his/her delegate shall access and
				review the record in the PMP at least every 90 days.
3. This Section shall not apply if:
a. the drug is prescribed or administered to
				a hospice patient or any other patient who has been diagnosed as terminally
				ill;
b. the drug is prescribed or
				administered for the treatment of cancer-related chronic or intractable
				pain;
c. the drug is ordered or
				administered to a patient being treated in a hospital;
d. the PMP is not accessible or not
				functioning properly due to an electronic issue. However, the prescriber shall
				check the PMP after electronic accessibility has been restored and note the
				cause for the delay in the patients chart; or
e. no more than a single seven-day supply of
				the drug is prescribed or administered to a patient.